- Home
- FTRE vs MLCO Comparison
FTRE vs MLCO Comparison
Compare FTRE & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTRE | MLCO |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2023 | 2006 |
Fundamental Metrics
Financial Performance| Metric | FTRE | MLCO |
|---|---|---|
| Price | $21.51 | $4.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $20.67 | $7.06 |
| AVG Volume (30 Days) | 1.3M | ★ 1.8M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,723,400,000.00 | N/A |
| Revenue This Year | N/A | $1.93 |
| Revenue Next Year | $3.05 | $4.38 |
| P/E Ratio | ★ N/A | $12.16 |
| Revenue Growth | ★ 1.00 | N/A |
| 52 Week Low | $8.55 | $4.07 |
| 52 Week High | $21.39 | $9.53 |
Technical Indicators
Market Signals| Indicator | FTRE | MLCO |
|---|---|---|
| Relative Strength Index (RSI) | 65.64 | 32.45 |
| Support Level | $15.94 | N/A |
| Resistance Level | N/A | $5.73 |
| Average True Range (ATR) | 1.08 | 0.15 |
| MACD | 0.14 | -0.03 |
| Stochastic Oscillator | 55.38 | 29.70 |
Price Performance
Historical ComparisonAbout FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 84% from Macao, with the rest from overseas as of 2025.